JAMA Dermatology

<jats:p>This cohort study investigates the potential therapeutic benefits of glucagon-like peptide-1 receptor agonists in patients with hidradenitis suppurativa.</jats:p>

Adipokines as an important link between hidradenitis suppurativa and obesity: a narrative review.

Br J Dermatol

Effects of exercise and dietary modifications on hidradenitis suppurativa: a systematic review.

Am J Clin Dermatol

Impact of semaglutide use in obese and diabetic patients with hidradenitis suppurativa.

J Eur Acad Dermatol Venereol

Liraglutide for the treatment of obesity among patients with hidradenitis suppurativa.

Med Clin (Barc)

Semaglutide for weight loss in people with obesity as an adjunctive treatment for hidradenitis suppurativa: its impact on disease control and quality of life.

Central glucagon-like peptide 1 receptor activation inhibits Toll-like receptor agonist-induced inflammation.

Cell Metab

This cohort study investigates the potential therapeutic benefits of glucagon-like peptide-1 receptor agonists in patients with hidradenitis suppurativa.

Glucagon-Like Peptide-1 Receptor Agonists in Hidradenitis Suppurativa.

Glucagon-Like Peptide-1 Receptor Agonists in Hidradenitis Suppurativa

Glucagon-Like Peptide-1 Receptor Agonists in Hidradenitis Suppurativa

Clinical Summary

What was studied

Related Questions